Publication related to RSI or an RSI staff member

Obstructive sleep apnea and hypertension in pediatric chronic kidney disease.

Authors

  • Tsampalieros, Anne, Tsampalieros A, Department of Pediatrics, Division of Nephrology, University of Ottawa, Children's Hospital of Eastern Ontario, 401 Smyth Road, Ottawa, ON, K1H 8L1, Canada.

  • Blinder, Henrietta, Blinder H, Children's Hospital of Eastern Ontario Research Institute, 401 Smyth Road, Ottawa, ON, K1H 5B2, Canada.; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, 600 Peter Morand Crescent, Ottawa, ON, K1G 5Z3, Canada.

  • Hoey, Lynda, Hoey L, Clinical Research Unit, Children's Hospital of Eastern Ontario Research Institute, 401 Smyth Road, Ottawa, ON, K1H 8L1, Canada.

  • Momoli, Franco, Momoli F, Children's Hospital of Eastern Ontario Research Institute, 401 Smyth Road, Ottawa, ON, K1H 5B2, Canada.; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, 600 Peter Morand Crescent, Ottawa, ON, K1G 5Z3, Canada.; Ottawa Hospital Research Institute, 501 Smyth Box 511, Ottawa, ON, K1H 8L6, Canada.

  • Barrowman, Nicholas, Barrowman N, Clinical Research Unit, Children's Hospital of Eastern Ontario Research Institute, 401 Smyth Road, Ottawa, ON, K1H 8L1, Canada.; Department of Pediatrics, Division of Respiratory Medicine, Children's Hospital of Eastern Ontario, University of Ottawa, 401 Smyth Road, Ottawa, ON, K1H 8L1, Canada.

  • Feber, Janusz, Feber J, Department of Pediatrics, Division of Nephrology, University of Ottawa, Children's Hospital of Eastern Ontario, 401 Smyth Road, Ottawa, ON, K1H 8L1, Canada.

  • Spitale, Naomi, Spitale N, Department of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada.

  • Katz, Sherri Lynne, Katz SL, Children's Hospital of Eastern Ontario Research Institute, 401 Smyth Road, Ottawa, ON, K1H 5B2, Canada. skatz@cheo.on.ca.; Department of Pediatrics, Division of Respiratory Medicine, Children's Hospital of Eastern Ontario, University of Ottawa, 401 Smyth Road, Ottawa, ON, K1H 8L1, Canada. skatz@cheo.on.ca.

YEAR OF PUBLICATION: 2019
SOURCE: Pediatr Nephrol. 2019 Nov;34(11):2361-2370. doi: 10.1007/s00467-019-04295-7. Epub 2019 Jun 28.
JOURNAL TITLE ABBREVIATION: Pediatr Nephrol
JOURNAL TITLE: Pediatric nephrology (Berlin, Germany)
ISSN: 1432-198X (Electronic) 0931-041X (Linking)
VOLUME: 34
ISSUE: 11
PAGES: 2361-2370
PLACE OF PUBLICATION: Germany
ABSTRACT:

BACKGROUND: Children with chronic kidney disease (CKD) are at risk for obstructive sleep apnea (OSA) and hypertension. The objectives of this study were to explore associations between OSA severity using the apnea-hypopnea-index(AHI) and obstructive apnea-hypopnea-index(OAHI) on polysomnography (PSG), OSA symptoms, and measures of hypertension in children with CKD. METHODS: One-night in-laboratory PSGs and 24-h ambulatory blood pressure monitoring (ABPM) were performed on children with CKD stages 2-5 (non-dialysis dependent). Sleep questionnaires, including the modified Epworth Sleepiness Scale (ESS) and the Pediatric Sleep Questionnaire (PSQ), were administered during the sleep study. RESULTS: Nineteen children and adolescents completed a PSG and questionnaires and thirteen completed ABPMs. Mean (standard deviation) age at the time of the sleep study was 14.1 (3.2) years. Eleven (58%) participants had CKD stage two, and eight (42%) had stage 3-4. None of the participants were found to have OSA on PSG. One participant had a positive ESS score (>/= 11) and five participants had positive PSQ scores (>/= eight). Night systolic and diastolic pressures were strongly correlated with the OAHI (r = 0.67 and r = 0.69, respectively, p

LANGUAGE: eng
DATE OF PUBLICATION: 2019 Nov
DATE OF ELECTRONIC PUBLICATION: 20190628
DATE COMPLETED: 20200824
DATE REVISED: 20200824
MESH DATE: 2020/08/25 06:00
EDAT: 2019/06/30 06:00
STATUS: MEDLINE
PUBLICATION STATUS: ppublish
LOCATION IDENTIFIER: 10.1007/s00467-019-04295-7 [doi]
OWNER: NLM

Related RSI Experts

Franco Momoli

Vice-President Chemical and Product Safety

Dr. Franco Momoli joined Risk Sciences International (RSI) in 2019 and currently serves as Vice-President, Chemical and Product Safety. In this role, he leads a multidisciplinary team of epidemiologists, risk assessors, toxicologists, and biostatisticians in conducting human health risk assessments...
Read More about Franco Momoli